Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rigel Pharmaceuticals
Pharma
Rigel snags Veppanu license from Pfizer, Arvinas for $85M
The deal includes up to $320 million in future milestone payments plus tiered royalties on Veppanu sales.
Zoey Becker
May 12, 2026 11:35am
Lilly's Retevmo succeeds as adjuvant treatment in NSCLC
Feb 17, 2026 11:02am
'The Top Line': Alzheimer's developments, plus this week's headlines
Dec 9, 2022 6:00am
Rigel's nod for Rezlidhia sets up battle with Servier in AML
Dec 2, 2022 9:57am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
FDA denies Rigel's Tavalisse an early EUA in COVID-19
Aug 13, 2021 10:52am
